NCT07576231

Brief Summary

The aim of this study is to determine the comparative effects of sacral release technique and lumbar mobilization in pain, symptoms severity and quality of life in primary dysmenorrhea.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
46

participants targeted

Target at P25-P50 for not_applicable

Timeline
2mo left

Started Oct 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress81%
Oct 2025Jul 2026

Study Start

First participant enrolled

October 1, 2025

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

May 4, 2026

Completed
4 days until next milestone

First Posted

Study publicly available on registry

May 8, 2026

Completed
24 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2026

Expected
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2026

Last Updated

May 8, 2026

Status Verified

May 1, 2026

Enrollment Period

8 months

First QC Date

May 4, 2026

Last Update Submit

May 4, 2026

Conditions

Keywords

dysmenorrheaadolescentgirlsfemalequality of life

Outcome Measures

Primary Outcomes (3)

  • Numerical Pain Rating Scale (NPRS)

    The Numerical Pain Rating Scale (NPRS) is a unidimensional scale ranging from 0 (no pain) to 10 (worst possible pain). The NPRS demonstrates excellent test-retest reliability, with Intraclass Correlation Coefficients (ICC) typically above 0.90, indicating stability of responses over time. Its internal consistency has been shown to be high, with Cronbach's alpha values ranging from 0.86 to 0.95, reflecting a strong degree of reliability. The tool also has validity as it correlates significantly with other pain-related outcome measures domains of quality-of-life instruments

    6th week

  • Menstrual Symptom Questionnaire (MSQ)

    It is a validated instrument designed to assess the frequency and intensity of common menstrual-related symptoms, including pain, mood changes, fatigue, bloating, and general discomfort. It provides a comprehensive overview of both physical and emotional aspects of menstruation, making it suitable for evaluating the effectiveness of interventions in conditions like primary dysmenorrhea. The scale demonstrates acceptable internal consistency, with a reported Cronbach's alpha of 0.78, indicating reliable measurement across diverse symptom domain

    6th week

  • EuroQol-5 Dimension Questionnaire (EQ-5D)

    The EuroQol-5 Dimension Questionnaire (EQ-5D) is assessing health-related quality of life in women with primary dysmenorrhea. The internal consistency of the EQ-5D in related populations have reported a Cronbach's alpha ranging from 0.70 to 0.89, indicating acceptable to excellent reliability

    6th week

Study Arms (2)

SACRAL RELEASE TECHNIQUE

EXPERIMENTAL

The sacral release technique is a gentle, non-invasive method used to relieve tension in the sacral area, improve pelvic alignment, and enhance overall comfort, particularly during pregnancy

Other: SACRAL RELEASE TECHNIQUE

LUMBAR MOBILIZATION

ACTIVE COMPARATOR

Lumbar mobilization is a manual therapy technique used to relieve pain, restore joint motion, and improve mobility in the lower spine.

Other: LUMBAR MOBILIZATION

Interventions

The therapist will maintain gentle, sustained holds for 3 to 5 minutes per repetition, with 2 to 3 repetitions per session. Each session lasted 15 to 20 minutes. 3 times per week over a period of two consecutive menstrual cycles, for six-weeks period

SACRAL RELEASE TECHNIQUE

Treatments will be administered three times per menstrual cycle over a six-weeks period

LUMBAR MOBILIZATION

Eligibility Criteria

Age13 Years - 19 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsPRIMARY DYSMENORREA
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Unmarried female
  • Diagnosed with primary dysmenorrhea through WaLIDD Score
  • Regular menstrual cycles (21-35 days)
  • Pain score of \> 4 on the Numerical Pain Rating Scale (NPRS) during menstruation

You may not qualify if:

  • Any pelvic inflammatory disease
  • Obesity
  • PCOS
  • Spinal deformity
  • Lumber radiculopathy
  • Heavy menstrual bleeding (menorrhagia)
  • Irregular menstrual cycles
  • Spine trauma and coccyx pain
  • History of pelvic or spinal surgery currently on hormonal therapy or other ongoing physiotherapy for dysmenorrhea

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ittefaq Hospital

Lahore, Punjab Province, 6400, Pakistan

RECRUITING

Related Publications (5)

  • Gottschewsky, N., D. Kraft, and T.J.B.o.s.D. Kaufmann, Menarche, pubertal timing and the brain: female-specific patterns of brain maturation beyond age-related development. 2024. 15(1): p. 25.

    BACKGROUND
  • Wu, X., et al., Age at Menarche, Menopause Status and Metabolic Syndrome and its Components: Findings from the Henan Rural Cohort Study. 2023. 131(09): p. 463-471.

    BACKGROUND
  • Qureshi, M.A., et al., Coping Mechanisms of Menopausal Women and Its Impact on the Quality of Life at Mohan Pura, Rawalpindi. 2025. 15(3): p. 197-202

    BACKGROUND
  • Rana, M.Y., et al., Factors influencing the age of menopause among Pakistani women. 2021. 11(3): p. 214-216.

    BACKGROUND
  • Keshwani, N., et al., Update in Adolescent Medicine, in Update in Pediatrics. 2024, Springer. p. 3-57.

    BACKGROUND

MeSH Terms

Conditions

Dysmenorrhea

Condition Hierarchy (Ancestors)

Menstruation DisturbancesPathologic ProcessesPathological Conditions, Signs and SymptomsPelvic PainPainNeurologic ManifestationsSigns and Symptoms

Study Officials

  • sobia ghafoor, t-DPT

    Riphah International University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 4, 2026

First Posted

May 8, 2026

Study Start

October 1, 2025

Primary Completion (Estimated)

June 1, 2026

Study Completion (Estimated)

July 1, 2026

Last Updated

May 8, 2026

Record last verified: 2026-05

Data Sharing

IPD Sharing
Will not share

Locations